anti-tnf
New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UC
The AGA has released a new, updated guideline on pharmacologic management of adult outpatients with ulcerative ...
NOVEMBER 26, 2024
Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024
Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.
NOVEMBER 19, 2024
IBD Clinical Trials at a Crossroads
Inflammatory bowel disease clinical trials are facing headwinds, with challenges in recruitment and trial design.
OCTOBER 22, 2024
The ABCs of Optimizing Drug Sequencing for IBD
The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...
OCTOBER 13, 2024
Combination Advanced Therapy in the Treatment of Inflammatory Bowel Disease
The development of effective biologics and small molecule targeted therapies has revolutionized the treatment of ...
SEPTEMBER 5, 2024
Study Looks at Infection Risk in Older IBD Patients on Immunosuppressive Therapies
Older adults represent a growing segment of patients with IBD, and several unique factors should be considered when ...
AUGUST 30, 2024
Early Anti-TNF Treatment Pivotal in Preventing Perianal Fistula in Pediatric Crohn’s Disease
Early administration of anti–tumor necrosis factor treatment significantly reduces the risk for perianal ...
JUNE 14, 2024
Equipoise at Risk With Placebo-Controlled Trials
The standard approach to randomized clinical trials for moderate to severe IBD causes harm to participants, ...
MAY 21, 2024
Treating Patients With Inflammatory Bowel Disease and Obesity
An estimated 41% of the US population is obese, including 22% of individuals aged 12 to 19 years, while nearly 1 of ...
MAY 10, 2024
Top-Down Therapy Proves Its Worth in Crohn’s Disease
Adults newly diagnosed with active Crohn’s disease benefit from immediate treatment with advanced therapies, ...
APRIL 22, 2024
Dual-Targeted Therapy in IBD Not Yet Ready for Prime Time
More evidence on the safety and efficacy of dual-targeted therapy for IBD is needed, according to presentations at ...
MARCH 20, 2023
STOP! CEASE! The Ongoing and Essential Question of When It’s Safe to Move Patients With Crohn’s Disease Off Anti-TNF Therapy
One of the first questions patients often ask before beginning a new therapy is, “How long will I have to ...
JANUARY 20, 2023
